Global Non-opioid Pain Patches Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Non-opioid Pain Patches Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Non-opioid Pain Patches report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Non-opioid Pain Patches market is projected to reach US$ 779.5 million in 2034, increasing from US$ 631.4 million in 2022, with the CAGR of 2.6% during the period of 2024 to 2034. Demand from Hospital Pharmacies and Independent Pharmacies & Drug Stores are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Non-opioid Pain Patches industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Non-opioid Pain Patches key manufacturers include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Hisamitsu Pharmaceutical, TEH SENG Pharmaceutical and Teikoku Seiyaku, etc. Pfizer, GlaxoSmithKline, Johnson & Johnson are top 3 players and held % sales share in total in 2022.
Non-opioid Pain Patches can be divided into Lidocaine Patch, Diclofenac Patch, Methyl Salicylate Patch and Capsaicin Patch, etc. Lidocaine Patch is the mainstream product in the market, accounting for % sales share globally in 2022.
Non-opioid Pain Patches is widely used in various fields, such as Hospital Pharmacies, Independent Pharmacies & Drug Stores and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Non-opioid Pain Patches industry development. In 2022, global % sales of Non-opioid Pain Patches went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-opioid Pain Patches market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Pfizer
GlaxoSmithKline
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International
Segment by Type
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Others
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Non-opioid Pain Patches market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Non-opioid Pain Patches, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Non-opioid Pain Patches industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Non-opioid Pain Patches in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Non-opioid Pain Patches introduction, etc. Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Non-opioid Pain Patches market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Non-opioid Pain Patches industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Non-opioid Pain Patches key manufacturers include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Hisamitsu Pharmaceutical, TEH SENG Pharmaceutical and Teikoku Seiyaku, etc. Pfizer, GlaxoSmithKline, Johnson & Johnson are top 3 players and held % sales share in total in 2022.
Non-opioid Pain Patches can be divided into Lidocaine Patch, Diclofenac Patch, Methyl Salicylate Patch and Capsaicin Patch, etc. Lidocaine Patch is the mainstream product in the market, accounting for % sales share globally in 2022.
Non-opioid Pain Patches is widely used in various fields, such as Hospital Pharmacies, Independent Pharmacies & Drug Stores and Online Pharmacies,, etc. Hospital Pharmacies provides greatest supports to the Non-opioid Pain Patches industry development. In 2022, global % sales of Non-opioid Pain Patches went into Hospital Pharmacies filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Non-opioid Pain Patches market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Pfizer
GlaxoSmithKline
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International
Segment by Type
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Others
Segment by Application
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Non-opioid Pain Patches market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Non-opioid Pain Patches, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Non-opioid Pain Patches industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Non-opioid Pain Patches in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Non-opioid Pain Patches introduction, etc. Non-opioid Pain Patches Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Non-opioid Pain Patches market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.